nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—CRABP2—mouth—Crohn's disease	0.0219	0.136	CbGeAlD
Alitretinoin—RARG—mouth—Crohn's disease	0.016	0.0993	CbGeAlD
Alitretinoin—CRABP1—skin of body—Crohn's disease	0.0134	0.0833	CbGeAlD
Alitretinoin—CRABP2—smooth muscle tissue—Crohn's disease	0.0123	0.0763	CbGeAlD
Alitretinoin—CRABP1—mammalian vulva—Crohn's disease	0.0122	0.0759	CbGeAlD
Alitretinoin—CRABP2—skin of body—Crohn's disease	0.0121	0.0753	CbGeAlD
Alitretinoin—CRABP2—mammalian vulva—Crohn's disease	0.0111	0.0687	CbGeAlD
Alitretinoin—CRABP2—digestive system—Crohn's disease	0.00971	0.0602	CbGeAlD
Alitretinoin—RARG—skin of body—Crohn's disease	0.00886	0.0549	CbGeAlD
Alitretinoin—RARG—mammalian vulva—Crohn's disease	0.00808	0.0501	CbGeAlD
Alitretinoin—RARG—digestive system—Crohn's disease	0.00709	0.0439	CbGeAlD
Alitretinoin—RARA—lymphoid tissue—Crohn's disease	0.00674	0.0418	CbGeAlD
Alitretinoin—RARB—lymph node—Crohn's disease	0.00496	0.0308	CbGeAlD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00473	0.068	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00444	0.064	CbGpPWpGaD
Alitretinoin—RARG—lymph node—Crohn's disease	0.00405	0.0251	CbGeAlD
Alitretinoin—RARA—lymph node—Crohn's disease	0.00381	0.0236	CbGeAlD
Alitretinoin—CYP1A2—digestive system—Crohn's disease	0.00247	0.0153	CbGeAlD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00234	0.0336	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MST1—Crohn's disease	0.00232	0.0333	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.0018	0.0259	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.0018	0.0259	CbGpPWpGaD
Alitretinoin—ABCB1—epithelium—Crohn's disease	0.00166	0.0103	CbGeAlD
Alitretinoin—Blood creatinine increased—Mesalazine—Crohn's disease	0.00166	0.00216	CcSEcCtD
Alitretinoin—Pancreatitis—Azathioprine—Crohn's disease	0.00165	0.00214	CcSEcCtD
Alitretinoin—Memory impairment—Prednisone—Crohn's disease	0.00164	0.00214	CcSEcCtD
Alitretinoin—Dry skin—Mesalazine—Crohn's disease	0.00162	0.00211	CcSEcCtD
Alitretinoin—Abdominal discomfort—Azathioprine—Crohn's disease	0.00161	0.00209	CcSEcCtD
Alitretinoin—Oedema—Mercaptopurine—Crohn's disease	0.0016	0.00208	CcSEcCtD
Alitretinoin—Nasopharyngitis—Mesalazine—Crohn's disease	0.00158	0.00206	CcSEcCtD
Alitretinoin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00157	0.00204	CcSEcCtD
Alitretinoin—Gastritis—Mesalazine—Crohn's disease	0.00157	0.00204	CcSEcCtD
Alitretinoin—Skin disorder—Mercaptopurine—Crohn's disease	0.00156	0.00202	CcSEcCtD
Alitretinoin—Abdominal distension—Mesalazine—Crohn's disease	0.00154	0.002	CcSEcCtD
Alitretinoin—Acne—Prednisone—Crohn's disease	0.00153	0.00199	CcSEcCtD
Alitretinoin—Asthma—Mesalazine—Crohn's disease	0.00153	0.00199	CcSEcCtD
Alitretinoin—Dysphagia—Mesalazine—Crohn's disease	0.00153	0.00199	CcSEcCtD
Alitretinoin—Anorexia—Mercaptopurine—Crohn's disease	0.00153	0.00199	CcSEcCtD
Alitretinoin—Pneumonia—Azathioprine—Crohn's disease	0.00151	0.00196	CcSEcCtD
Alitretinoin—Bronchospasm—Mesalazine—Crohn's disease	0.0015	0.00196	CcSEcCtD
Alitretinoin—Pancreatitis—Mesalazine—Crohn's disease	0.0015	0.00195	CcSEcCtD
Alitretinoin—Infestation NOS—Azathioprine—Crohn's disease	0.0015	0.00195	CcSEcCtD
Alitretinoin—Infestation—Azathioprine—Crohn's disease	0.0015	0.00195	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00148	0.00193	CcSEcCtD
Alitretinoin—Contusion—Prednisone—Crohn's disease	0.00148	0.00192	CcSEcCtD
Alitretinoin—Abdominal discomfort—Mesalazine—Crohn's disease	0.00147	0.00191	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00146	0.0019	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00146	0.021	CbGpPWpGaD
Alitretinoin—ABCB1—mammalian vulva—Crohn's disease	0.00144	0.00895	CbGeAlD
Alitretinoin—Dysuria—Mesalazine—Crohn's disease	0.00143	0.00186	CcSEcCtD
Alitretinoin—Neutropenia—Mesalazine—Crohn's disease	0.00143	0.00186	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00142	0.00185	CcSEcCtD
Alitretinoin—Pollakiuria—Mesalazine—Crohn's disease	0.00141	0.00184	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.0014	0.0201	CbGpPWpGaD
Alitretinoin—Agranulocytosis—Azathioprine—Crohn's disease	0.0014	0.00182	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.0014	0.00181	CcSEcCtD
Alitretinoin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00139	0.00181	CcSEcCtD
Alitretinoin—Weight increased—Mesalazine—Crohn's disease	0.00139	0.00181	CcSEcCtD
Alitretinoin—Weight decreased—Mesalazine—Crohn's disease	0.00138	0.0018	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00138	0.0018	CcSEcCtD
Alitretinoin—Leukocytosis—Prednisone—Crohn's disease	0.00137	0.00178	CcSEcCtD
Alitretinoin—Pneumonia—Mesalazine—Crohn's disease	0.00137	0.00178	CcSEcCtD
Alitretinoin—Infestation NOS—Mesalazine—Crohn's disease	0.00136	0.00177	CcSEcCtD
Alitretinoin—Infestation—Mesalazine—Crohn's disease	0.00136	0.00177	CcSEcCtD
Alitretinoin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00136	0.00177	CcSEcCtD
Alitretinoin—Ulcer—Prednisone—Crohn's disease	0.00136	0.00177	CcSEcCtD
Alitretinoin—Depression—Mesalazine—Crohn's disease	0.00136	0.00177	CcSEcCtD
Alitretinoin—Cataract—Prednisone—Crohn's disease	0.00135	0.00176	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00135	0.00176	CcSEcCtD
Alitretinoin—Haemoglobin—Azathioprine—Crohn's disease	0.00135	0.00176	CcSEcCtD
Alitretinoin—Haemorrhage—Azathioprine—Crohn's disease	0.00134	0.00175	CcSEcCtD
Alitretinoin—Renal failure—Mesalazine—Crohn's disease	0.00134	0.00174	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Mesalazine—Crohn's disease	0.00134	0.00174	CcSEcCtD
Alitretinoin—Stomatitis—Mesalazine—Crohn's disease	0.00133	0.00173	CcSEcCtD
Alitretinoin—Conjunctivitis—Mesalazine—Crohn's disease	0.00133	0.00172	CcSEcCtD
Alitretinoin—Urinary tract infection—Mesalazine—Crohn's disease	0.00133	0.00172	CcSEcCtD
Alitretinoin—Vasculitis—Prednisone—Crohn's disease	0.00132	0.00172	CcSEcCtD
Alitretinoin—Sweating—Mesalazine—Crohn's disease	0.00131	0.0017	CcSEcCtD
Alitretinoin—Haematuria—Mesalazine—Crohn's disease	0.0013	0.00169	CcSEcCtD
Alitretinoin—Epistaxis—Mesalazine—Crohn's disease	0.00129	0.00167	CcSEcCtD
Alitretinoin—ABCB1—lymphoid tissue—Crohn's disease	0.00128	0.00794	CbGeAlD
Alitretinoin—Sinusitis—Mesalazine—Crohn's disease	0.00128	0.00166	CcSEcCtD
Alitretinoin—Agranulocytosis—Mesalazine—Crohn's disease	0.00127	0.00165	CcSEcCtD
Alitretinoin—Erythema multiforme—Azathioprine—Crohn's disease	0.00127	0.00165	CcSEcCtD
Alitretinoin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00127	0.00165	CcSEcCtD
Alitretinoin—ABCB1—digestive system—Crohn's disease	0.00127	0.00785	CbGeAlD
Alitretinoin—Skin exfoliation—Prednisone—Crohn's disease	0.00123	0.0016	CcSEcCtD
Alitretinoin—Haemoglobin—Mesalazine—Crohn's disease	0.00123	0.0016	CcSEcCtD
Alitretinoin—Haemorrhage—Mesalazine—Crohn's disease	0.00122	0.00159	CcSEcCtD
Alitretinoin—Hepatitis—Mesalazine—Crohn's disease	0.00122	0.00159	CcSEcCtD
Alitretinoin—Pharyngitis—Mesalazine—Crohn's disease	0.00121	0.00158	CcSEcCtD
Alitretinoin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00121	0.00157	CcSEcCtD
Alitretinoin—Oedema peripheral—Mesalazine—Crohn's disease	0.00121	0.00157	CcSEcCtD
Alitretinoin—Chills—Azathioprine—Crohn's disease	0.00121	0.00157	CcSEcCtD
Alitretinoin—Arrhythmia—Azathioprine—Crohn's disease	0.0012	0.00156	CcSEcCtD
Alitretinoin—Urethral disorder—Mesalazine—Crohn's disease	0.0012	0.00156	CcSEcCtD
Alitretinoin—Alopecia—Azathioprine—Crohn's disease	0.00119	0.00154	CcSEcCtD
Alitretinoin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00118	0.00153	CcSEcCtD
Alitretinoin—Oesophagitis—Prednisone—Crohn's disease	0.00118	0.00153	CcSEcCtD
Alitretinoin—Erythema multiforme—Mesalazine—Crohn's disease	0.00116	0.0015	CcSEcCtD
Alitretinoin—Pulmonary oedema—Prednisone—Crohn's disease	0.00115	0.00149	CcSEcCtD
Alitretinoin—Eye disorder—Mesalazine—Crohn's disease	0.00114	0.00149	CcSEcCtD
Alitretinoin—Tinnitus—Mesalazine—Crohn's disease	0.00114	0.00148	CcSEcCtD
Alitretinoin—Sepsis—Prednisone—Crohn's disease	0.00112	0.00146	CcSEcCtD
Alitretinoin—Angiopathy—Mesalazine—Crohn's disease	0.00111	0.00144	CcSEcCtD
Alitretinoin—Euphoric mood—Prednisone—Crohn's disease	0.00111	0.00144	CcSEcCtD
Alitretinoin—Chills—Mesalazine—Crohn's disease	0.0011	0.00143	CcSEcCtD
Alitretinoin—Diarrhoea—Mercaptopurine—Crohn's disease	0.0011	0.00143	CcSEcCtD
Alitretinoin—RXRA—Recycling of bile acids and salts—ALB—Crohn's disease	0.00109	0.0156	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00109	0.00141	CcSEcCtD
Alitretinoin—Alopecia—Mesalazine—Crohn's disease	0.00108	0.00141	CcSEcCtD
Alitretinoin—Anaemia—Azathioprine—Crohn's disease	0.00108	0.00141	CcSEcCtD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00108	0.0156	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00108	0.0156	CbGpPWpGaD
Alitretinoin—Diabetes mellitus—Prednisone—Crohn's disease	0.00108	0.0014	CcSEcCtD
Alitretinoin—Mental disorder—Mesalazine—Crohn's disease	0.00107	0.00139	CcSEcCtD
Alitretinoin—Erythema—Mesalazine—Crohn's disease	0.00107	0.00139	CcSEcCtD
Alitretinoin—Malaise—Azathioprine—Crohn's disease	0.00106	0.00137	CcSEcCtD
Alitretinoin—Flatulence—Mesalazine—Crohn's disease	0.00105	0.00137	CcSEcCtD
Alitretinoin—Tension—Mesalazine—Crohn's disease	0.00105	0.00136	CcSEcCtD
Alitretinoin—Nervousness—Mesalazine—Crohn's disease	0.00104	0.00135	CcSEcCtD
Alitretinoin—Cardiac failure congestive—Prednisone—Crohn's disease	0.00103	0.00134	CcSEcCtD
Alitretinoin—Back pain—Mesalazine—Crohn's disease	0.00103	0.00134	CcSEcCtD
Alitretinoin—Vomiting—Mercaptopurine—Crohn's disease	0.00102	0.00132	CcSEcCtD
Alitretinoin—Rash—Mercaptopurine—Crohn's disease	0.00101	0.00131	CcSEcCtD
Alitretinoin—Dermatitis—Mercaptopurine—Crohn's disease	0.00101	0.00131	CcSEcCtD
Alitretinoin—Vision blurred—Mesalazine—Crohn's disease	0.001	0.00131	CcSEcCtD
Alitretinoin—Tremor—Mesalazine—Crohn's disease	0.000998	0.0013	CcSEcCtD
Alitretinoin—Myalgia—Azathioprine—Crohn's disease	0.000996	0.00129	CcSEcCtD
Alitretinoin—Arthralgia—Azathioprine—Crohn's disease	0.000996	0.00129	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000989	0.00129	CcSEcCtD
Alitretinoin—Ill-defined disorder—Mesalazine—Crohn's disease	0.000989	0.00129	CcSEcCtD
Alitretinoin—Anaemia—Mesalazine—Crohn's disease	0.000985	0.00128	CcSEcCtD
Alitretinoin—Discomfort—Azathioprine—Crohn's disease	0.000984	0.00128	CcSEcCtD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000971	0.014	CbGpPWpGaD
Alitretinoin—Malaise—Mesalazine—Crohn's disease	0.000961	0.00125	CcSEcCtD
Alitretinoin—Cardiac failure—Prednisone—Crohn's disease	0.000959	0.00125	CcSEcCtD
Alitretinoin—Syncope—Mesalazine—Crohn's disease	0.000956	0.00124	CcSEcCtD
Alitretinoin—Lethargy—Prednisone—Crohn's disease	0.000955	0.00124	CcSEcCtD
Alitretinoin—Nausea—Mercaptopurine—Crohn's disease	0.000952	0.00124	CcSEcCtD
Alitretinoin—Infection—Azathioprine—Crohn's disease	0.000949	0.00123	CcSEcCtD
Alitretinoin—Palpitations—Mesalazine—Crohn's disease	0.000942	0.00122	CcSEcCtD
Alitretinoin—Loss of consciousness—Mesalazine—Crohn's disease	0.000937	0.00122	CcSEcCtD
Alitretinoin—Osteoarthritis—Prednisone—Crohn's disease	0.000936	0.00122	CcSEcCtD
Alitretinoin—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000936	0.00122	CcSEcCtD
Alitretinoin—Thrombocytopenia—Azathioprine—Crohn's disease	0.000935	0.00122	CcSEcCtD
Alitretinoin—Cough—Mesalazine—Crohn's disease	0.00093	0.00121	CcSEcCtD
Alitretinoin—Skin disorder—Azathioprine—Crohn's disease	0.000927	0.00121	CcSEcCtD
Alitretinoin—Affect lability—Prednisone—Crohn's disease	0.000922	0.0012	CcSEcCtD
Alitretinoin—Hypertension—Mesalazine—Crohn's disease	0.00092	0.0012	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000919	0.0132	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000919	0.0132	CbGpPWpGaD
Alitretinoin—Psychotic disorder—Prednisone—Crohn's disease	0.000914	0.00119	CcSEcCtD
Alitretinoin—Myalgia—Mesalazine—Crohn's disease	0.000907	0.00118	CcSEcCtD
Alitretinoin—Chest pain—Mesalazine—Crohn's disease	0.000907	0.00118	CcSEcCtD
Alitretinoin—Arthralgia—Mesalazine—Crohn's disease	0.000907	0.00118	CcSEcCtD
Alitretinoin—Anxiety—Mesalazine—Crohn's disease	0.000904	0.00118	CcSEcCtD
Alitretinoin—Face oedema—Prednisone—Crohn's disease	0.000904	0.00118	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000901	0.00117	CcSEcCtD
Alitretinoin—Discomfort—Mesalazine—Crohn's disease	0.000896	0.00117	CcSEcCtD
Alitretinoin—Irritability—Prednisone—Crohn's disease	0.000894	0.00116	CcSEcCtD
Alitretinoin—Hypotension—Azathioprine—Crohn's disease	0.000892	0.00116	CcSEcCtD
Alitretinoin—Cardiac arrest—Prednisone—Crohn's disease	0.00089	0.00116	CcSEcCtD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000888	0.0128	CbGpPWpGaD
Alitretinoin—Dry mouth—Mesalazine—Crohn's disease	0.000887	0.00115	CcSEcCtD
Alitretinoin—Mood swings—Prednisone—Crohn's disease	0.000887	0.00115	CcSEcCtD
Alitretinoin—Confusional state—Mesalazine—Crohn's disease	0.000877	0.00114	CcSEcCtD
Alitretinoin—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000871	0.0125	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00087	0.00113	CcSEcCtD
Alitretinoin—Oedema—Mesalazine—Crohn's disease	0.00087	0.00113	CcSEcCtD
Alitretinoin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00087	0.00113	CcSEcCtD
Alitretinoin—Infection—Mesalazine—Crohn's disease	0.000864	0.00112	CcSEcCtD
Alitretinoin—Dry skin—Prednisone—Crohn's disease	0.000858	0.00112	CcSEcCtD
Alitretinoin—Shock—Mesalazine—Crohn's disease	0.000856	0.00111	CcSEcCtD
Alitretinoin—Nervous system disorder—Mesalazine—Crohn's disease	0.000853	0.00111	CcSEcCtD
Alitretinoin—Thrombocytopenia—Mesalazine—Crohn's disease	0.000852	0.00111	CcSEcCtD
Alitretinoin—Tachycardia—Mesalazine—Crohn's disease	0.000849	0.0011	CcSEcCtD
Alitretinoin—Skin disorder—Mesalazine—Crohn's disease	0.000845	0.0011	CcSEcCtD
Alitretinoin—Hyperhidrosis—Mesalazine—Crohn's disease	0.000841	0.00109	CcSEcCtD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000835	0.012	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000835	0.012	CbGpPWpGaD
Alitretinoin—Anorexia—Mesalazine—Crohn's disease	0.000829	0.00108	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000824	0.00107	CcSEcCtD
Alitretinoin—Abdominal distension—Prednisone—Crohn's disease	0.000815	0.00106	CcSEcCtD
Alitretinoin—Hypotension—Mesalazine—Crohn's disease	0.000813	0.00106	CcSEcCtD
Alitretinoin—RXRA—PPARA activates gene expression—FADS1—Crohn's disease	0.000807	0.0116	CbGpPWpGaD
Alitretinoin—Pancreatitis—Prednisone—Crohn's disease	0.000793	0.00103	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000792	0.00103	CcSEcCtD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00079	0.0114	CbGpPWpGaD
Alitretinoin—Sweating increased—Prednisone—Crohn's disease	0.000788	0.00102	CcSEcCtD
Alitretinoin—Feeling abnormal—Azathioprine—Crohn's disease	0.000787	0.00102	CcSEcCtD
Alitretinoin—Insomnia—Mesalazine—Crohn's disease	0.000787	0.00102	CcSEcCtD
Alitretinoin—Paraesthesia—Mesalazine—Crohn's disease	0.000781	0.00102	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000781	0.00102	CcSEcCtD
Alitretinoin—Dyspnoea—Mesalazine—Crohn's disease	0.000775	0.00101	CcSEcCtD
Alitretinoin—Somnolence—Mesalazine—Crohn's disease	0.000773	0.00101	CcSEcCtD
Alitretinoin—Dyspepsia—Mesalazine—Crohn's disease	0.000766	0.000995	CcSEcCtD
Alitretinoin—Neutropenia—Prednisone—Crohn's disease	0.000757	0.000984	CcSEcCtD
Alitretinoin—Decreased appetite—Mesalazine—Crohn's disease	0.000756	0.000983	CcSEcCtD
Alitretinoin—Body temperature increased—Azathioprine—Crohn's disease	0.000755	0.000981	CcSEcCtD
Alitretinoin—Abdominal pain—Azathioprine—Crohn's disease	0.000755	0.000981	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000751	0.000976	CcSEcCtD
Alitretinoin—Fatigue—Mesalazine—Crohn's disease	0.00075	0.000975	CcSEcCtD
Alitretinoin—Constipation—Mesalazine—Crohn's disease	0.000744	0.000967	CcSEcCtD
Alitretinoin—Pain—Mesalazine—Crohn's disease	0.000744	0.000967	CcSEcCtD
Alitretinoin—Weight increased—Prednisone—Crohn's disease	0.000736	0.000957	CcSEcCtD
Alitretinoin—Weight decreased—Prednisone—Crohn's disease	0.000732	0.000952	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000729	0.0105	CbGpPWpGaD
Alitretinoin—ABCB1—lymph node—Crohn's disease	0.000723	0.00448	CbGeAlD
Alitretinoin—Depression—Prednisone—Crohn's disease	0.000719	0.000935	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—SOCS1—Crohn's disease	0.000718	0.0103	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Mesalazine—Crohn's disease	0.000717	0.000932	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000716	0.0103	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000716	0.0103	CbGpPWpGaD
Alitretinoin—Acute coronary syndrome—Prednisone—Crohn's disease	0.000711	0.000925	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000711	0.000925	CcSEcCtD
Alitretinoin—Myocardial infarction—Prednisone—Crohn's disease	0.000707	0.000919	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Prednisone—Crohn's disease	0.000707	0.000919	CcSEcCtD
Alitretinoin—Hypersensitivity—Azathioprine—Crohn's disease	0.000703	0.000915	CcSEcCtD
Alitretinoin—Urticaria—Mesalazine—Crohn's disease	0.000691	0.000898	CcSEcCtD
Alitretinoin—Body temperature increased—Mesalazine—Crohn's disease	0.000688	0.000894	CcSEcCtD
Alitretinoin—Abdominal pain—Mesalazine—Crohn's disease	0.000688	0.000894	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—SOCS1—Crohn's disease	0.000675	0.00971	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000671	0.00965	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000671	0.00965	CbGpPWpGaD
Alitretinoin—Diarrhoea—Azathioprine—Crohn's disease	0.000653	0.000849	CcSEcCtD
Alitretinoin—Haemoglobin—Prednisone—Crohn's disease	0.000651	0.000846	CcSEcCtD
Alitretinoin—Haemorrhage—Prednisone—Crohn's disease	0.000648	0.000842	CcSEcCtD
Alitretinoin—Hallucination—Prednisone—Crohn's disease	0.000644	0.000838	CcSEcCtD
Alitretinoin—Hypersensitivity—Mesalazine—Crohn's disease	0.000641	0.000833	CcSEcCtD
Alitretinoin—Dizziness—Azathioprine—Crohn's disease	0.000631	0.000821	CcSEcCtD
Alitretinoin—Asthenia—Mesalazine—Crohn's disease	0.000624	0.000811	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—SMAD3—Crohn's disease	0.00062	0.00892	CbGpPWpGaD
Alitretinoin—Pruritus—Mesalazine—Crohn's disease	0.000615	0.0008	CcSEcCtD
Alitretinoin—Vomiting—Azathioprine—Crohn's disease	0.000607	0.000789	CcSEcCtD
Alitretinoin—Eye disorder—Prednisone—Crohn's disease	0.000605	0.000787	CcSEcCtD
Alitretinoin—Rash—Azathioprine—Crohn's disease	0.000602	0.000783	CcSEcCtD
Alitretinoin—Dermatitis—Azathioprine—Crohn's disease	0.000601	0.000782	CcSEcCtD
Alitretinoin—Flushing—Prednisone—Crohn's disease	0.000601	0.000781	CcSEcCtD
Alitretinoin—Headache—Azathioprine—Crohn's disease	0.000598	0.000778	CcSEcCtD
Alitretinoin—Diarrhoea—Mesalazine—Crohn's disease	0.000595	0.000774	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000591	0.0085	CbGpPWpGaD
Alitretinoin—Angiopathy—Prednisone—Crohn's disease	0.000588	0.000764	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—SMAD3—Crohn's disease	0.000583	0.00839	CbGpPWpGaD
Alitretinoin—Arrhythmia—Prednisone—Crohn's disease	0.000579	0.000752	CcSEcCtD
Alitretinoin—Dizziness—Mesalazine—Crohn's disease	0.000575	0.000748	CcSEcCtD
Alitretinoin—Alopecia—Prednisone—Crohn's disease	0.000572	0.000744	CcSEcCtD
Alitretinoin—RXRA—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.000568	0.00817	CbGpPWpGaD
Alitretinoin—Mental disorder—Prednisone—Crohn's disease	0.000567	0.000738	CcSEcCtD
Alitretinoin—Nausea—Azathioprine—Crohn's disease	0.000567	0.000737	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000566	0.00815	CbGpPWpGaD
Alitretinoin—Erythema—Prednisone—Crohn's disease	0.000564	0.000733	CcSEcCtD
Alitretinoin—Malnutrition—Prednisone—Crohn's disease	0.000564	0.000733	CcSEcCtD
Alitretinoin—Vomiting—Mesalazine—Crohn's disease	0.000553	0.000719	CcSEcCtD
Alitretinoin—RARG—Gene Expression—PTRF—Crohn's disease	0.000552	0.00794	CbGpPWpGaD
Alitretinoin—Rash—Mesalazine—Crohn's disease	0.000548	0.000713	CcSEcCtD
Alitretinoin—Dermatitis—Mesalazine—Crohn's disease	0.000548	0.000712	CcSEcCtD
Alitretinoin—Headache—Mesalazine—Crohn's disease	0.000545	0.000708	CcSEcCtD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.000544	0.00784	CbGpPWpGaD
Alitretinoin—Vision blurred—Prednisone—Crohn's disease	0.000531	0.000691	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.000526	0.00757	CbGpPWpGaD
Alitretinoin—Ill-defined disorder—Prednisone—Crohn's disease	0.000523	0.00068	CcSEcCtD
Alitretinoin—Anaemia—Prednisone—Crohn's disease	0.000521	0.000677	CcSEcCtD
Alitretinoin—Agitation—Prednisone—Crohn's disease	0.000518	0.000674	CcSEcCtD
Alitretinoin—Nausea—Mesalazine—Crohn's disease	0.000517	0.000672	CcSEcCtD
Alitretinoin—Malaise—Prednisone—Crohn's disease	0.000508	0.000661	CcSEcCtD
Alitretinoin—Syncope—Prednisone—Crohn's disease	0.000506	0.000657	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—PTRF—Crohn's disease	0.000505	0.00726	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—TNF—Crohn's disease	0.000497	0.00716	CbGpPWpGaD
Alitretinoin—Loss of consciousness—Prednisone—Crohn's disease	0.000496	0.000644	CcSEcCtD
Alitretinoin—RARB—Gene Expression—PTRF—Crohn's disease	0.000495	0.00712	CbGpPWpGaD
Alitretinoin—Convulsion—Prednisone—Crohn's disease	0.000489	0.000635	CcSEcCtD
Alitretinoin—Hypertension—Prednisone—Crohn's disease	0.000487	0.000633	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—PLA2G4F—Crohn's disease	0.000482	0.00693	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PLA2G4F—Crohn's disease	0.000482	0.00693	CbGpPWpGaD
Alitretinoin—Myalgia—Prednisone—Crohn's disease	0.00048	0.000624	CcSEcCtD
Alitretinoin—Arthralgia—Prednisone—Crohn's disease	0.00048	0.000624	CcSEcCtD
Alitretinoin—Anxiety—Prednisone—Crohn's disease	0.000478	0.000622	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000477	0.00062	CcSEcCtD
Alitretinoin—RARA—Gene Expression—PTRF—Crohn's disease	0.000475	0.00683	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PTRF—Crohn's disease	0.000475	0.00683	CbGpPWpGaD
Alitretinoin—Discomfort—Prednisone—Crohn's disease	0.000474	0.000617	CcSEcCtD
Alitretinoin—Oedema—Prednisone—Crohn's disease	0.00046	0.000598	CcSEcCtD
Alitretinoin—Anaphylactic shock—Prednisone—Crohn's disease	0.00046	0.000598	CcSEcCtD
Alitretinoin—Infection—Prednisone—Crohn's disease	0.000457	0.000594	CcSEcCtD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000453	0.00652	CbGpPWpGaD
Alitretinoin—Shock—Prednisone—Crohn's disease	0.000453	0.000589	CcSEcCtD
Alitretinoin—Nervous system disorder—Prednisone—Crohn's disease	0.000451	0.000587	CcSEcCtD
Alitretinoin—Tachycardia—Prednisone—Crohn's disease	0.000449	0.000584	CcSEcCtD
Alitretinoin—Skin disorder—Prednisone—Crohn's disease	0.000447	0.000581	CcSEcCtD
Alitretinoin—Hyperhidrosis—Prednisone—Crohn's disease	0.000445	0.000578	CcSEcCtD
Alitretinoin—Anorexia—Prednisone—Crohn's disease	0.000439	0.00057	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.000435	0.00626	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000419	0.000545	CcSEcCtD
Alitretinoin—Insomnia—Prednisone—Crohn's disease	0.000416	0.000541	CcSEcCtD
Alitretinoin—Paraesthesia—Prednisone—Crohn's disease	0.000413	0.000537	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—MTMR3—Crohn's disease	0.000409	0.00589	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MTMR3—Crohn's disease	0.000409	0.00589	CbGpPWpGaD
Alitretinoin—Dyspepsia—Prednisone—Crohn's disease	0.000405	0.000527	CcSEcCtD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IL6—Crohn's disease	0.000401	0.00578	CbGpPWpGaD
Alitretinoin—Decreased appetite—Prednisone—Crohn's disease	0.0004	0.00052	CcSEcCtD
Alitretinoin—Fatigue—Prednisone—Crohn's disease	0.000397	0.000516	CcSEcCtD
Alitretinoin—Constipation—Prednisone—Crohn's disease	0.000394	0.000512	CcSEcCtD
Alitretinoin—Feeling abnormal—Prednisone—Crohn's disease	0.000379	0.000493	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000376	0.000489	CcSEcCtD
Alitretinoin—Urticaria—Prednisone—Crohn's disease	0.000366	0.000475	CcSEcCtD
Alitretinoin—Abdominal pain—Prednisone—Crohn's disease	0.000364	0.000473	CcSEcCtD
Alitretinoin—Body temperature increased—Prednisone—Crohn's disease	0.000364	0.000473	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—SOCS1—Crohn's disease	0.000352	0.00506	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000346	0.00498	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Prednisone—Crohn's disease	0.000339	0.000441	CcSEcCtD
Alitretinoin—RARG—Gene Expression—ZFP36L1—Crohn's disease	0.000331	0.00476	CbGpPWpGaD
Alitretinoin—Asthenia—Prednisone—Crohn's disease	0.00033	0.000429	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000327	0.00471	CbGpPWpGaD
Alitretinoin—Pruritus—Prednisone—Crohn's disease	0.000326	0.000423	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—FADS1—Crohn's disease	0.000319	0.00459	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—FADS1—Crohn's disease	0.000319	0.00459	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000316	0.00455	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000316	0.00455	CbGpPWpGaD
Alitretinoin—Diarrhoea—Prednisone—Crohn's disease	0.000315	0.000409	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00031	0.00446	CbGpPWpGaD
Alitretinoin—Dizziness—Prednisone—Crohn's disease	0.000304	0.000396	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—SMAD3—Crohn's disease	0.000304	0.00437	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—ZFP36L1—Crohn's disease	0.000302	0.00435	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GPX4—Crohn's disease	0.000299	0.0043	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GPX4—Crohn's disease	0.000299	0.0043	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000297	0.00428	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000297	0.00428	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—ZFP36L1—Crohn's disease	0.000297	0.00427	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000295	0.00425	CbGpPWpGaD
Alitretinoin—Vomiting—Prednisone—Crohn's disease	0.000293	0.00038	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000291	0.00419	CbGpPWpGaD
Alitretinoin—Rash—Prednisone—Crohn's disease	0.00029	0.000377	CcSEcCtD
Alitretinoin—Dermatitis—Prednisone—Crohn's disease	0.00029	0.000377	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—GCKR—Crohn's disease	0.000288	0.00415	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GCKR—Crohn's disease	0.000288	0.00415	CbGpPWpGaD
Alitretinoin—Headache—Prednisone—Crohn's disease	0.000288	0.000375	CcSEcCtD
Alitretinoin—RXRB—Gene Expression—ZFP36L1—Crohn's disease	0.000284	0.00409	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ZFP36L1—Crohn's disease	0.000284	0.00409	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT3—Crohn's disease	0.000283	0.00407	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—DNMT3A—Crohn's disease	0.000281	0.00405	CbGpPWpGaD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000279	0.00402	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000278	0.00401	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000276	0.00398	CbGpPWpGaD
Alitretinoin—Nausea—Prednisone—Crohn's disease	0.000273	0.000355	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—STAT3—Crohn's disease	0.000266	0.00383	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000265	0.00381	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000265	0.00381	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000262	0.00377	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—DNMT3A—Crohn's disease	0.000257	0.0037	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000257	0.0037	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—DNMT3A—Crohn's disease	0.000252	0.00363	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000251	0.00361	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000247	0.00356	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PTRF—Crohn's disease	0.000247	0.00356	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—TNF—Crohn's disease	0.000245	0.00353	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—DNMT3A—Crohn's disease	0.000242	0.00348	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—DNMT3A—Crohn's disease	0.000242	0.00348	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—TNF—Crohn's disease	0.00023	0.00332	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000226	0.00326	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000222	0.00319	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000217	0.00312	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000213	0.00306	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000213	0.00306	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000209	0.003	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000206	0.00297	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000206	0.00297	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000203	0.00292	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IL6—Crohn's disease	0.000198	0.00285	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—HSPA1B—Crohn's disease	0.00019	0.00273	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000188	0.0027	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000186	0.00268	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IL6—Crohn's disease	0.000186	0.00268	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—TNF—Crohn's disease	0.000183	0.00263	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.00018	0.0026	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.00018	0.0026	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000177	0.00254	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—HSPA1B—Crohn's disease	0.000174	0.0025	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—HSPA1B—Crohn's disease	0.00017	0.00245	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000169	0.00244	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000167	0.00241	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—UBE2D1—Crohn's disease	0.000167	0.0024	CbGpPWpGaD
Alitretinoin—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000166	0.00239	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000165	0.00237	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—HSPA1B—Crohn's disease	0.000163	0.00235	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—HSPA1B—Crohn's disease	0.000163	0.00235	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000155	0.00223	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—UBE2D1—Crohn's disease	0.000152	0.00219	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—UBE2D1—Crohn's disease	0.000149	0.00215	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ZFP36L1—Crohn's disease	0.000148	0.00213	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G4F—Crohn's disease	0.000146	0.0021	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—UBE2D1—Crohn's disease	0.000143	0.00206	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—UBE2D1—Crohn's disease	0.000143	0.00206	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—Crohn's disease	0.000139	0.002	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000136	0.00196	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000131	0.00188	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.00013	0.00187	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—DNMT3A—Crohn's disease	0.000126	0.00181	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTMR3—Crohn's disease	0.000124	0.00178	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000122	0.00175	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000121	0.00174	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—TNF—Crohn's disease	0.00012	0.00173	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SMAD3—Crohn's disease	0.000119	0.00171	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000118	0.0017	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000111	0.0016	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IFNG—Crohn's disease	0.00011	0.00159	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SMAD3—Crohn's disease	0.000109	0.00157	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SMAD3—Crohn's disease	0.000107	0.00154	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000106	0.00152	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000106	0.00152	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000104	0.0015	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SMAD3—Crohn's disease	0.000104	0.0015	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	0.000103	0.00148	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SMAD3—Crohn's disease	0.000102	0.00147	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SMAD3—Crohn's disease	0.000102	0.00147	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL1B—Crohn's disease	9.85e-05	0.00142	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—Crohn's disease	9.69e-05	0.00139	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—FADS1—Crohn's disease	9.66e-05	0.00139	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—Crohn's disease	9.18e-05	0.00132	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—Crohn's disease	9.18e-05	0.00132	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GPX4—Crohn's disease	9.04e-05	0.0013	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	8.88e-05	0.00128	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	8.83e-05	0.00127	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	8.8e-05	0.00127	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	8.8e-05	0.00127	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCKR—Crohn's disease	8.73e-05	0.00126	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—HSPA1B—Crohn's disease	8.51e-05	0.00122	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—Crohn's disease	8.03e-05	0.00116	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—Crohn's disease	8.03e-05	0.00116	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—UBE2D1—Crohn's disease	7.46e-05	0.00107	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.45e-05	0.00107	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—Crohn's disease	7.15e-05	0.00103	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	6.92e-05	0.000995	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TYK2—Crohn's disease	6.81e-05	0.00098	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.59e-05	0.000948	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—JAK2—Crohn's disease	6.5e-05	0.000935	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.48e-05	0.000932	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.24e-05	0.000898	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—Crohn's disease	5.93e-05	0.000854	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G4F—Crohn's disease	5.83e-05	0.000838	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.46e-05	0.000786	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SMAD3—Crohn's disease	5.34e-05	0.000768	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	5.23e-05	0.000752	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTMR3—Crohn's disease	4.95e-05	0.000713	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—Crohn's disease	4.77e-05	0.000686	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	4.65e-05	0.000669	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—Crohn's disease	4.13e-05	0.000594	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTMR3—Crohn's disease	3.95e-05	0.000569	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FADS1—Crohn's disease	3.86e-05	0.000555	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GPX4—Crohn's disease	3.61e-05	0.00052	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	3.53e-05	0.000508	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCKR—Crohn's disease	3.49e-05	0.000502	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—Crohn's disease	3.33e-05	0.000479	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FADS1—Crohn's disease	3.08e-05	0.000443	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GPX4—Crohn's disease	2.88e-05	0.000415	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCKR—Crohn's disease	2.79e-05	0.000401	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—Crohn's disease	2.78e-05	0.0004	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—Crohn's disease	2.43e-05	0.00035	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.37e-05	0.000341	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.99e-05	0.000287	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.74e-05	0.000251	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—Crohn's disease	1.11e-05	0.00016	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—Crohn's disease	9.72e-06	0.00014	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—Crohn's disease	8.87e-06	0.000128	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—Crohn's disease	7.76e-06	0.000112	CbGpPWpGaD
